Tudor Investment Corp
PTLA

Tudor Investment Corp’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Tudor Investment Corp’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-83,891
Closed -$2M – 1462
2019
Q4 		$2M Buy
83,891
+1,103
+1% +$30.4K 0.09% 283
2019
Q3 		$2.22M Buy
82,788
+19,043
+30% +$535K 0.08% 286
2019
Q2 		$1.73M Buy
+63,745
New +$2M 0.05% 378
2018
Q1 		– Sell
-7,580
Closed -$369K – 1356
2017
Q4 		$369K Sell
7,580
-24,381
-76% -$1.23M 0.01% 725
2017
Q3 		$1.73M Buy
31,961
+15,542
+95% +$912K 0.04% 244
2017
Q2 		$922K Buy
+16,419
New +$658K 0.03% 371
2016
Q3 		– Sell
-24,761
Closed -$584K – 1830
2016
Q2 		$584K Sell
24,761
-5,681
-19% -$140K 0.01% 734
2016
Q1 		$621K Buy
30,442
+5,901
+24% +$187K 0.02% 810
2015
Q4 		$1.26M Buy
24,541
+12,327
+101% +$598K 0.04% 358
2015
Q3 		$521K Buy
+12,214
New +$589K 0.02% 760
2015
Q2 		– Sell
-6,016
Closed -$228K – 1744
2015
Q1 		$228K Buy
+6,016
New +$207K 0.01% 1225

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Tudor Investment Corp's PTLA Position: Q1 2020 in Review

Tudor Investment Corp sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 83,891 shares — an estimated $2M sold.

Tudor Investment Corp first reported a position in PTLA in Q1 2015 and held it in 11 quarters. The position peaked at $2.22M in Q3 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • Tudor Investment Corp reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Tudor Investment Corp sold 83,891 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $2M.
  • Tudor Investment Corp first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 11 quarters.
  • Tudor Investment Corp's Portola Pharmaceuticals, Inc. position peaked at $2.22M in Q3 2019.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Tudor Investment Corp's 13F filing for Q1 2020, filed 15 May 2020.